Evidence map›Paper›PMID 25245075›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells.

Shakila Tobwala, Ahdab Khayyat, Weili Fan, Nuran Ercal

Open access · greenAbstract readComparative Study
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Redefining the role of the thiol-based agentRSC medicinal chemistry · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Protective Effects of Ganoderic Acids fromFoods (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Medicinal Thiols: Current Status and New Perspectives.Mini reviews in medicinal chemistry · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effect of amlodipine, lisinopril and allopurinol on acetaminophen-induced hepatotoxicity in rats.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2016
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shakila TobwalaDepartment of Chemistry, Missouri University of Science and Technology, Rolla, MO 65409, USA.
Ahdab KhayyatDepartment of Chemistry, Missouri University of Science and Technology, Rolla, MO 65409, USA.
Weili FanDepartment of Chemistry, Missouri University of Science and Technology, Rolla, MO 65409, USA.
Nuran ErcalDepartment of Chemistry, Missouri University of Science and Technology, Rolla, MO 65409, USA nercal@mst.edu.
Missouri University of Science and Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (N-acetyl-p-aminophenol, APAP) is one of the most widely used over-the-counter antipyretic analgesic medications. Despite being safe at therapeutic doses, an accidental or intentional overdose can result in severe hepatotoxicity; a leading cause of drug-induced liver failure in the U.S. Depletion of glutathione (GSH) is implicated as an initiating event in APAP-induced toxicity. N-acetylcysteine (NAC), a GSH precursor, is the only currently approved antidote for an APAP overdose. Unfortunately, fairly high doses and longer treatment times are required due to its poor bioavailability. In addition, oral and intravenous administration of NAC in a hospital setting are laborious and costly. Therefore, we studied the protective effects of N-acetylcysteineamide (NACA), a novel antioxidant, with higher bioavailability and compared it with NAC in APAP-induced hepatotoxicity in a human-relevant in vitro system, HepaRG. Our results indicated that exposure of HepaRG cells to APAP resulted in GSH depletion, reactive oxygen species (ROS) formation, increased lipid peroxidation, mitochondrial dysfunction (assessed by JC-1 fluorescence), and lactate dehydrogenase release. Both NAC and NACA protected against APAP-induced hepatotoxicity by restoring GSH levels, scavenging ROS, inhibiting lipid peroxidation, and preserving mitochondrial membrane potential. However, NACA was better than NAC at combating oxidative stress and protecting against APAP-induced damage. The higher efficiency of NACA in protecting cells against APAP-induced toxicity suggests that NACA can be developed into a promising therapeutic option for treatment of an APAP overdose.

Indexed as

AcetaminophenAcetylcysteineAnalgesics, Non-NarcoticAntidotesCarcinoma, HepatocellularCell Line, TumorDrug OverdoseFree Radical ScavengersHumansLipid PeroxidationLiver NeoplasmsMitochondria, LiverOxidative StressReactive Oxygen SpeciesAcetaminophenAcetylcysteineAnalgesics, Non-NarcoticAntidotesFree Radical ScavengersN-AcetylcysteinamideReactive Oxygen SpeciesglutathioneGlutathione-prodrugmitochondriaN-acetyl-p-benzoquinoneimineoxidative stress

Identifiers

PMID25245075
PMCPMC4935326
OpenAlexW2320966492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.